Retrolental Fibroplasia: Causes, Symptoms

Retrolental fibroplasia, also known as retinopathy of prematurity, is a condition that affects premature infants' eyes. This disease occurs when abnormal blood vessels grow in the retina, the tissue at the back of the eye responsible for vision. The main cause of retrolental fibroplasia is the incomplete development of blood vessels in the premature infant's eyes.

Factors such as low birth weight, premature birth, and exposure to high levels of oxygen during the neonatal period can contribute to the development of this condition. It is essential for healthcare providers to closely monitor premature infants for signs of retrolental fibroplasia to prevent any potential vision problems in the future.

Symptoms of Retrolental Fibroplasia

Retrolental fibroplasia, also known as retinopathy of prematurity, can cause various symptoms in newborns. It is essential to seek medical attention if you notice any of these signs in a newborn, as early detection and treatment are crucial in managing this condition.

Blurred vision is a common symptom of retrolental fibroplasia, affecting the clarity of sight.
Strabismus, where the eyes are misaligned, is often observed in individuals with retrolental fibroplasia.
White pupils, known as leukocoria, can be a noticeable sign of retrolental fibroplasia in affected individuals.
Excessive sensitivity to light, termed photophobia, is a symptom that may manifest in those with retrolental fibroplasia.
In severe cases, retinal detachment can occur, leading to vision loss and requiring immediate medical attention.

Get a second opinion from trusted experts and makeconfident, informed decisions.

Get Second Opinion

Causes of Retrolental Fibroplasia

The main causes include exposure to high levels of oxygen in neonatal care, leading to abnormal vessel growth and scarring. Early detection and management are crucial in preventing long-term complications associated with retrolental fibroplasia.

Premature birth is a significant risk factor for developing retrolental fibroplasia due to the immature blood vessels in the eyes.
Oxygen therapy, particularly high levels, can damage the developing blood vessels in premature infants' eyes, leading to retrolental fibroplasia.
Inadequate prenatal care or exposure to certain maternal risk factors during pregnancy can increase the likelihood of retrolental fibroplasia in newborns.
Genetic predisposition or inherited conditions may contribute to the development of retrolental fibroplasia in some infants.
Neonatal infections or other medical complications during the neonatal period can trigger the onset of retrolental fibroplasia in vulnerable infants.

Types Of Retrolental Fibroplasia

Retrolental fibroplasia, also known as retinopathy of prematurity (ROP), can be categorized into two main types based on the severity and extent of the condition: Stage 1 ROP involves a demarcation line between vascularized and nonvascularized retina, while Stage 2 ROP features a ridge that extends into the vitreous from the retina. Early detection and intervention are essential in addressing retrolental fibroplasia to optimize visual outcomes in affected individuals.

Stage 1: Mild form characterized by dilated blood vessels at the periphery of the retina.
Stage 2: More advanced, with abnormal growth of blood vessels extending into the vitreous.
Stage 3: Severe form with extensive fibrovascular proliferation leading to retinal detachment.
Stage 4: Total retinal detachment causing permanent vision loss.
Stage 5: End-stage with the formation of a retrolental membrane and severe vision impairment.

Risk Factors

Retrolental fibroplasia, a condition primarily affecting premature infants, has several recognized risk factors. These include a low gestational age, low birth weight, prolonged supplemental oxygen therapy, and certain medical interventions like blood transfusions. Understanding and managing these risk factors are crucial in preventing or minimizing the impact of this condition on vulnerable infants.

Premature birth, especially before 32 weeks' gestation, increases the risk of retrolental fibroplasia in infants.
Low birth weight, particularly below 1,500 grams, is a significant risk factor for the development of retrolental fibroplasia.
Prolonged exposure to high levels of oxygen therapy in premature infants is associated with an increased risk of retrolental fibroplasia.
Maternal factors such as preeclampsia and gestational diabetes can contribute to the likelihood of retrolental fibroplasia in newborns.
Inadequate prenatal care and nutritional deficiencies during pregnancy may elevate the risk of retrolental fibroplasia in newborns.

Your health is everything - prioritize your well-being today.

Schedule Your Appointment

Diagnosis of Retrolental Fibroplasia

Ophthalmologists typically conduct a comprehensive eye examination to evaluate the presence of abnormal blood vessel growth behind the lens. This assessment may include visual acuity testing, fundus examination, and imaging studies like retinal photography or ultrasound. Early detection is crucial in managing this condition effectively to prevent vision loss or other complications, emphasizing the importance of regular screenings for at-risk infants.

Ophthalmologic examination including indirect ophthalmoscopy.
Evaluation of retinal blood vessels for abnormal growth.
Imaging studies such as retinal photography or fluorescein angiography.
Assessment of visual function using electroretinography.
Monitoring of oxygen levels to prevent retinopathy of prematurity.
Collaboration with pediatricians to manage risk factors.

Treatment for Retrolental Fibroplasia

Retrolental fibroplasia, also known as retinopathy of prematurity, requires a multidisciplinary approach for effective treatment. Some common treatment options include laser therapy, cryotherapy, and anti-VEGF injections to address abnormal blood vessel growth in the retina. In severe cases, surgical interventions like vitrectomy may be necessary.

Early detection through regular eye examinations in premature infants is crucial for timely intervention and management. Close monitoring and individualized treatment plans are essential to prevent vision loss and promote optimal visual development in infants affected by retrolental fibroplasia.

Find Our Specialists

Book Doctor Appointment

Name*

Mobile Number*

I agree to the Medicover Privacy Policy

International Patient Services

Still have questions? Speak with our experts now!

040-68334455

Frequently Asked Questions

What are the common signs of Retrolental fibroplasia?

Common signs of Retrolental fibroplasia include abnormal blood vessel growth in the retina, retinal detachment, and vision problems.

How should I care for myself with Retrolental fibroplasia—what should I do and avoid?

Follow your doctor's advice, attend regular check-ups, take prescribed medications, protect eyes from bright light, and avoid smoking around the baby.

What serious complications could arise from Retrolental fibroplasia?

Retinal detachment, blindness, and visual impairment are serious complications of Retrolental fibroplasia.

What steps should I take for the management of Retrolental fibroplasia?

Consult an ophthalmologist for proper diagnosis and treatment options. Regular eye exams and early intervention can help in managing Retrolental Fibroplasia effectively.